aluates Reports

$ 0.0

Automative

Global Sleep-Wake Disorder Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-38H8783

Global Sleep Wake Disorder Market Research Report 2022

BUY CHAPTERS

Global Sleep-Wake Disorder Market Research Report 2025

Code: QYRE-Auto-38H8783

Report

June 2025

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Jazz Pharmaceuticals

Koninklijke Philips N V

Merck KGaA

Neurocrine Biosciences

Medtronic Inc

Teva Pharmaceutical Industries Ltd

Vanda Pharmaceuticals, Inc.

RespireRx Pharmaceuticals Inc.

Sleep-Wake Disorder Market Size

The global market for Sleep-Wake Disorder was valued at US$ 19700 million in the year 2024 and is projected to reach a revised size of US$ 31830 million by 2031, growing at a CAGR of 7.2% during the forecast period.

Sleep-Wake Disorder Market

The sleep-wake disorder is a sign of an impending condition such as bipolar disorder. Sleep disorders range from insomnia disorder to narcolepsy and breathing-related disorder to restless leg syndrome.

The major factors driving the market include the increasing incidences of sleep apnea, an increase in the geriatric population, an increase in the prevalence of obesity and hypertension, and increasing awareness among the patient population in developing countries. Aging is a major factor driving the market growth for sleep apnea devices as the elderly are the most at risk for developing this disorder.

This report aims to provide a comprehensive presentation of the global market for Sleep-Wake Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep-Wake Disorder.

The Sleep-Wake Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sleep-Wake Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sleep-Wake Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Sleep-Wake Disorder Market Report

Report Metric	Details
Report Name	Sleep-Wake Disorder Market
Accounted market size in year	US$ 19700 million
Forecasted market size in 2031	US$ 31830 million
CAGR	7.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Insomnia Hypersomnia Sleep Apnea Circadian Rhythm Disorders Others
Segment by Application	Therapies Medications Devices
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Jazz Pharmaceuticals, Koninklijke Philips N.V., Merck KGaA, Neurocrine Biosciences, RespireRx Pharmaceuticals Inc., Medtronic PLC, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleep-Wake Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Sleep-Wake Disorder Market growing?

Ans: The Sleep-Wake Disorder Market witnessing a CAGR of 7.2% during the forecast period 2025-2031.

What is the Sleep-Wake Disorder Market size in 2031?

Ans: The Sleep-Wake Disorder Market size in 2031 will be US$ 31830 million.

Who are the main players in the Sleep-Wake Disorder Market report?

Ans: The main players in the Sleep-Wake Disorder Market are Jazz Pharmaceuticals, Koninklijke Philips N.V., Merck KGaA, Neurocrine Biosciences, RespireRx Pharmaceuticals Inc., Medtronic PLC, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc.

What are the Application segmentation covered in the Sleep-Wake Disorder Market report?

Ans: The Applications covered in the Sleep-Wake Disorder Market report are Therapies, Medications, Devices

What are the Type segmentation covered in the Sleep-Wake Disorder Market report?

Ans: The Types covered in the Sleep-Wake Disorder Market report are Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Disorders, Others

Recommended Reports

Sleep Apnea Devices

Sleep Monitoring Equipment

Sleep Therapy & Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sleep-Wake Disorder Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Insomnia

1.2.3 Hypersomnia

1.2.4 Sleep Apnea

1.2.5 Circadian Rhythm Disorders

1.2.6 Others

1.2.7 Insomnia

1.2.8 Hypersomnia

1.2.9 Sleep Apnea

1.2.10 Circadian Rhythm Disorders

1.3 Market by Application

1.3.1 Global Sleep-Wake Disorder Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Therapies

1.3.3 Medications

1.3.4 Devices

1.3.5 Therapies

1.3.6 Medications

1.3.7 Devices

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sleep-Wake Disorder Market Perspective (2020-2031)

2.2 Global Sleep-Wake Disorder Growth Trends by Region

2.2.1 Global Sleep-Wake Disorder Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Sleep-Wake Disorder Historic Market Size by Region (2020-2025)

2.2.3 Sleep-Wake Disorder Forecasted Market Size by Region (2026-2031)

2.3 Sleep-Wake Disorder Market Dynamics

2.3.1 Sleep-Wake Disorder Industry Trends

2.3.2 Sleep-Wake Disorder Market Drivers

2.3.3 Sleep-Wake Disorder Market Challenges

2.3.4 Sleep-Wake Disorder Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sleep-Wake Disorder Players by Revenue

3.1.1 Global Top Sleep-Wake Disorder Players by Revenue (2020-2025)

3.1.2 Global Sleep-Wake Disorder Revenue Market Share by Players (2020-2025)

3.2 Global Sleep-Wake Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Sleep-Wake Disorder Revenue

3.4 Global Sleep-Wake Disorder Market Concentration Ratio

3.4.1 Global Sleep-Wake Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sleep-Wake Disorder Revenue in 2024

3.5 Global Key Players of Sleep-Wake Disorder Head office and Area Served

3.6 Global Key Players of Sleep-Wake Disorder, Product and Application

3.7 Global Key Players of Sleep-Wake Disorder, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Sleep-Wake Disorder Breakdown Data by Type

4.1 Global Sleep-Wake Disorder Historic Market Size by Type (2020-2025)

4.2 Global Sleep-Wake Disorder Forecasted Market Size by Type (2026-2031)

5 Sleep-Wake Disorder Breakdown Data by Application

5.1 Global Sleep-Wake Disorder Historic Market Size by Application (2020-2025)

5.2 Global Sleep-Wake Disorder Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Sleep-Wake Disorder Market Size (2020-2031)

6.2 North America Sleep-Wake Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Sleep-Wake Disorder Market Size by Country (2020-2025)

6.4 North America Sleep-Wake Disorder Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sleep-Wake Disorder Market Size (2020-2031)

7.2 Europe Sleep-Wake Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Sleep-Wake Disorder Market Size by Country (2020-2025)

7.4 Europe Sleep-Wake Disorder Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sleep-Wake Disorder Market Size (2020-2031)

8.2 Asia-Pacific Sleep-Wake Disorder Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Sleep-Wake Disorder Market Size by Region (2020-2025)

8.4 Asia-Pacific Sleep-Wake Disorder Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Sleep-Wake Disorder Market Size (2020-2031)

9.2 Latin America Sleep-Wake Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Sleep-Wake Disorder Market Size by Country (2020-2025)

9.4 Latin America Sleep-Wake Disorder Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sleep-Wake Disorder Market Size (2020-2031)

10.2 Middle East & Africa Sleep-Wake Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Sleep-Wake Disorder Market Size by Country (2020-2025)

10.4 Middle East & Africa Sleep-Wake Disorder Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Jazz Pharmaceuticals

11.1.1 Jazz Pharmaceuticals Company Details

11.1.2 Jazz Pharmaceuticals Business Overview

11.1.3 Jazz Pharmaceuticals Sleep-Wake Disorder Introduction

11.1.4 Jazz Pharmaceuticals Revenue in Sleep-Wake Disorder Business (2020-2025)

11.1.5 Jazz Pharmaceuticals Recent Development

11.2 Koninklijke Philips N.V.

11.2.1 Koninklijke Philips N.V. Company Details

11.2.2 Koninklijke Philips N.V. Business Overview

11.2.3 Koninklijke Philips N.V. Sleep-Wake Disorder Introduction

11.2.4 Koninklijke Philips N.V. Revenue in Sleep-Wake Disorder Business (2020-2025)

11.2.5 Koninklijke Philips N.V. Recent Development

11.3 Merck KGaA

11.3.1 Merck KGaA Company Details

11.3.2 Merck KGaA Business Overview

11.3.3 Merck KGaA Sleep-Wake Disorder Introduction

11.3.4 Merck KGaA Revenue in Sleep-Wake Disorder Business (2020-2025)

11.3.5 Merck KGaA Recent Development

11.4 Neurocrine Biosciences

11.4.1 Neurocrine Biosciences Company Details

11.4.2 Neurocrine Biosciences Business Overview

11.4.3 Neurocrine Biosciences Sleep-Wake Disorder Introduction

11.4.4 Neurocrine Biosciences Revenue in Sleep-Wake Disorder Business (2020-2025)

11.4.5 Neurocrine Biosciences Recent Development

11.5 RespireRx Pharmaceuticals Inc.

11.5.1 RespireRx Pharmaceuticals Inc. Company Details

11.5.2 RespireRx Pharmaceuticals Inc. Business Overview

11.5.3 RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Introduction

11.5.4 RespireRx Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2020-2025)

11.5.5 RespireRx Pharmaceuticals Inc. Recent Development

11.6 Medtronic PLC

11.6.1 Medtronic PLC Company Details

11.6.2 Medtronic PLC Business Overview

11.6.3 Medtronic PLC Sleep-Wake Disorder Introduction

11.6.4 Medtronic PLC Revenue in Sleep-Wake Disorder Business (2020-2025)

11.6.5 Medtronic PLC Recent Development

11.7 Teva Pharmaceutical Industries Ltd.

11.7.1 Teva Pharmaceutical Industries Ltd. Company Details

11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.7.3 Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Introduction

11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Sleep-Wake Disorder Business (2020-2025)

11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.8 Vanda Pharmaceuticals Inc.

11.8.1 Vanda Pharmaceuticals Inc. Company Details

11.8.2 Vanda Pharmaceuticals Inc. Business Overview

11.8.3 Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Introduction

11.8.4 Vanda Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2020-2025)

11.8.5 Vanda Pharmaceuticals Inc. Recent Development

11.9 Jazz Pharmaceuticals

11.9.1 Jazz Pharmaceuticals Company Details

11.9.2 Jazz Pharmaceuticals Business Overview

11.9.3 Jazz Pharmaceuticals Sleep-Wake Disorder Introduction

11.9.4 Jazz Pharmaceuticals Revenue in Sleep-Wake Disorder Business (2020-2025)

11.9.5 Jazz Pharmaceuticals Recent Development

11.10 Koninklijke Philips N.V.

11.10.1 Koninklijke Philips N.V. Company Details

11.10.2 Koninklijke Philips N.V. Business Overview

11.10.3 Koninklijke Philips N.V. Sleep-Wake Disorder Introduction

11.10.4 Koninklijke Philips N.V. Revenue in Sleep-Wake Disorder Business (2020-2025)

11.10.5 Koninklijke Philips N.V. Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Details

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Sleep-Wake Disorder Introduction

11.11.4 Merck KGaA Revenue in Sleep-Wake Disorder Business (2020-2025)

11.11.5 Merck KGaA Recent Development

11.12 Neurocrine Biosciences

11.12.1 Neurocrine Biosciences Company Details

11.12.2 Neurocrine Biosciences Business Overview

11.12.3 Neurocrine Biosciences Sleep-Wake Disorder Introduction

11.12.4 Neurocrine Biosciences Revenue in Sleep-Wake Disorder Business (2020-2025)

11.12.5 Neurocrine Biosciences Recent Development

11.13 RespireRx Pharmaceuticals Inc.

11.13.1 RespireRx Pharmaceuticals Inc. Company Details

11.13.2 RespireRx Pharmaceuticals Inc. Business Overview

11.13.3 RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Introduction

11.13.4 RespireRx Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2020-2025)

11.13.5 RespireRx Pharmaceuticals Inc. Recent Development

11.14 Medtronic PLC

11.14.1 Medtronic PLC Company Details

11.14.2 Medtronic PLC Business Overview

11.14.3 Medtronic PLC Sleep-Wake Disorder Introduction

11.14.4 Medtronic PLC Revenue in Sleep-Wake Disorder Business (2020-2025)

11.14.5 Medtronic PLC Recent Development

11.15 Teva Pharmaceutical Industries Ltd.

11.15.1 Teva Pharmaceutical Industries Ltd. Company Details

11.15.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.15.3 Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Introduction

11.15.4 Teva Pharmaceutical Industries Ltd. Revenue in Sleep-Wake Disorder Business (2020-2025)

11.15.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.16 Vanda Pharmaceuticals Inc.

11.16.1 Vanda Pharmaceuticals Inc. Company Details

11.16.2 Vanda Pharmaceuticals Inc. Business Overview

11.16.3 Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Introduction

11.16.4 Vanda Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2020-2025)

11.16.5 Vanda Pharmaceuticals Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Jazz Pharmaceuticals

Koninklijke Philips N V

Merck KGaA

Neurocrine Biosciences

Medtronic Inc

Teva Pharmaceutical Industries Ltd

Vanda Pharmaceuticals, Inc.

RespireRx Pharmaceuticals Inc.

List of Tables

Table 1. Global Sleep-Wake Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Insomnia

Table 3. Key Players of Hypersomnia

Table 4. Key Players of Sleep Apnea

Table 5. Key Players of Circadian Rhythm Disorders

Table 6. Key Players of Others

Table 7. Key Players of Insomnia

Table 8. Key Players of Hypersomnia

Table 9. Global Sleep-Wake Disorder Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Sleep-Wake Disorder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Sleep-Wake Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Sleep-Wake Disorder Market Share by Region (2020-2025)

Table 13. Global Sleep-Wake Disorder Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Sleep-Wake Disorder Market Share by Region (2026-2031)

Table 15. Sleep-Wake Disorder Market Trends

Table 16. Sleep-Wake Disorder Market Drivers

Table 17. Sleep-Wake Disorder Market Challenges

Table 18. Sleep-Wake Disorder Market Restraints

Table 19. Global Sleep-Wake Disorder Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Sleep-Wake Disorder Market Share by Players (2020-2025)

Table 21. Global Top Sleep-Wake Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep-Wake Disorder as of 2024)

Table 22. Ranking of Global Top Sleep-Wake Disorder Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Sleep-Wake Disorder Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Sleep-Wake Disorder, Headquarters and Area Served

Table 25. Global Key Players of Sleep-Wake Disorder, Product and Application

Table 26. Global Key Players of Sleep-Wake Disorder, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Sleep-Wake Disorder Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Sleep-Wake Disorder Revenue Market Share by Type (2020-2025)

Table 30. Global Sleep-Wake Disorder Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Sleep-Wake Disorder Revenue Market Share by Type (2026-2031)

Table 32. Global Sleep-Wake Disorder Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Sleep-Wake Disorder Revenue Market Share by Application (2020-2025)

Table 34. Global Sleep-Wake Disorder Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Sleep-Wake Disorder Revenue Market Share by Application (2026-2031)

Table 36. North America Sleep-Wake Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Sleep-Wake Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Sleep-Wake Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Sleep-Wake Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Sleep-Wake Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Sleep-Wake Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Sleep-Wake Disorder Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Sleep-Wake Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Sleep-Wake Disorder Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Sleep-Wake Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Sleep-Wake Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Sleep-Wake Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Sleep-Wake Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Sleep-Wake Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Sleep-Wake Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 51. Jazz Pharmaceuticals Company Details

Table 52. Jazz Pharmaceuticals Business Overview

Table 53. Jazz Pharmaceuticals Sleep-Wake Disorder Product

Table 54. Jazz Pharmaceuticals Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 55. Jazz Pharmaceuticals Recent Development

Table 56. Koninklijke Philips N.V. Company Details

Table 57. Koninklijke Philips N.V. Business Overview

Table 58. Koninklijke Philips N.V. Sleep-Wake Disorder Product

Table 59. Koninklijke Philips N.V. Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 60. Koninklijke Philips N.V. Recent Development

Table 61. Merck KGaA Company Details

Table 62. Merck KGaA Business Overview

Table 63. Merck KGaA Sleep-Wake Disorder Product

Table 64. Merck KGaA Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 65. Merck KGaA Recent Development

Table 66. Neurocrine Biosciences Company Details

Table 67. Neurocrine Biosciences Business Overview

Table 68. Neurocrine Biosciences Sleep-Wake Disorder Product

Table 69. Neurocrine Biosciences Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 70. Neurocrine Biosciences Recent Development

Table 71. RespireRx Pharmaceuticals Inc. Company Details

Table 72. RespireRx Pharmaceuticals Inc. Business Overview

Table 73. RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Product

Table 74. RespireRx Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 75. RespireRx Pharmaceuticals Inc. Recent Development

Table 76. Medtronic PLC Company Details

Table 77. Medtronic PLC Business Overview

Table 78. Medtronic PLC Sleep-Wake Disorder Product

Table 79. Medtronic PLC Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 80. Medtronic PLC Recent Development

Table 81. Teva Pharmaceutical Industries Ltd. Company Details

Table 82. Teva Pharmaceutical Industries Ltd. Business Overview

Table 83. Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Product

Table 84. Teva Pharmaceutical Industries Ltd. Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 85. Teva Pharmaceutical Industries Ltd. Recent Development

Table 86. Vanda Pharmaceuticals Inc. Company Details

Table 87. Vanda Pharmaceuticals Inc. Business Overview

Table 88. Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Product

Table 89. Vanda Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 90. Vanda Pharmaceuticals Inc. Recent Development

Table 91. Jazz Pharmaceuticals Company Details

Table 92. Jazz Pharmaceuticals Business Overview

Table 93. Jazz Pharmaceuticals Sleep-Wake Disorder Product

Table 94. Jazz Pharmaceuticals Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 95. Jazz Pharmaceuticals Recent Development

Table 96. Koninklijke Philips N.V. Company Details

Table 97. Koninklijke Philips N.V. Business Overview

Table 98. Koninklijke Philips N.V. Sleep-Wake Disorder Product

Table 99. Koninklijke Philips N.V. Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 100. Koninklijke Philips N.V. Recent Development

Table 101. Merck KGaA Company Details

Table 102. Merck KGaA Business Overview

Table 103. Merck KGaA Sleep-Wake Disorder Product

Table 104. Merck KGaA Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 105. Merck KGaA Recent Development

Table 106. Neurocrine Biosciences Company Details

Table 107. Neurocrine Biosciences Business Overview

Table 108. Neurocrine Biosciences Sleep-Wake Disorder Product

Table 109. Neurocrine Biosciences Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 110. Neurocrine Biosciences Recent Development

Table 111. RespireRx Pharmaceuticals Inc. Company Details

Table 112. RespireRx Pharmaceuticals Inc. Business Overview

Table 113. RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Product

Table 114. RespireRx Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 115. RespireRx Pharmaceuticals Inc. Recent Development

Table 116. Medtronic PLC Company Details

Table 117. Medtronic PLC Business Overview

Table 118. Medtronic PLC Sleep-Wake Disorder Product

Table 119. Medtronic PLC Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 120. Medtronic PLC Recent Development

Table 121. Teva Pharmaceutical Industries Ltd. Company Details

Table 122. Teva Pharmaceutical Industries Ltd. Business Overview

Table 123. Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Product

Table 124. Teva Pharmaceutical Industries Ltd. Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 125. Teva Pharmaceutical Industries Ltd. Recent Development

Table 126. Vanda Pharmaceuticals Inc. Company Details

Table 127. Vanda Pharmaceuticals Inc. Business Overview

Table 128. Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Product

Table 129. Vanda Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2020-2025) & (US$ Million)

Table 130. Vanda Pharmaceuticals Inc. Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Sleep-Wake Disorder Picture

Figure 2. Global Sleep-Wake Disorder Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sleep-Wake Disorder Market Share by Type: 2024 VS 2031

Figure 4. Insomnia Features

Figure 5. Hypersomnia Features

Figure 6. Sleep Apnea Features

Figure 7. Circadian Rhythm Disorders Features

Figure 8. Others Features

Figure 9. Insomnia Features

Figure 10. Hypersomnia Features

Figure 11. Sleep Apnea Features

Figure 12. Circadian Rhythm Disorders Features

Figure 13. Global Sleep-Wake Disorder Market Size by Application (2020-2031) & (US$ Million)

Figure 14. Global Sleep-Wake Disorder Market Share by Application: 2024 VS 2031

Figure 15. Therapies Case Studies

Figure 16. Medications Case Studies

Figure 17. Devices Case Studies

Figure 18. Therapies Case Studies

Figure 19. Medications Case Studies

Figure 20. Devices Case Studies

Figure 21. Sleep-Wake Disorder Report Years Considered

Figure 22. Global Sleep-Wake Disorder Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 23. Global Sleep-Wake Disorder Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 24. Global Sleep-Wake Disorder Market Share by Region: 2024 VS 2031

Figure 25. Global Sleep-Wake Disorder Market Share by Players in 2024

Figure 26. Global Top Sleep-Wake Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep-Wake Disorder as of 2024)

Figure 27. The Top 10 and 5 Players Market Share by Sleep-Wake Disorder Revenue in 2024

Figure 28. North America Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. North America Sleep-Wake Disorder Market Share by Country (2020-2031)

Figure 30. United States Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Canada Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Sleep-Wake Disorder Market Share by Country (2020-2031)

Figure 34. Germany Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. France Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. U.K. Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Italy Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Russia Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Nordic Countries Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Sleep-Wake Disorder Market Share by Region (2020-2031)

Figure 42. China Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Japan Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. South Korea Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. India Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Australia Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Sleep-Wake Disorder Market Share by Country (2020-2031)

Figure 50. Mexico Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Brazil Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Sleep-Wake Disorder Market Share by Country (2020-2031)

Figure 54. Turkey Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. UAE Sleep-Wake Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Jazz Pharmaceuticals Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 58. Koninklijke Philips N.V. Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 59. Merck KGaA Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 60. Neurocrine Biosciences Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 61. RespireRx Pharmaceuticals Inc. Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 62. Medtronic PLC Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 64. Vanda Pharmaceuticals Inc. Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 65. Jazz Pharmaceuticals Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 66. Koninklijke Philips N.V. Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 67. Merck KGaA Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 68. Neurocrine Biosciences Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 69. RespireRx Pharmaceuticals Inc. Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 70. Medtronic PLC Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 71. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 72. Vanda Pharmaceuticals Inc. Revenue Growth Rate in Sleep-Wake Disorder Business (2020-2025)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Sleep Disorder Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Bipolar Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non 24 hour Sleep wake Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sleep Disorder Therapies Market Research Report 2024

Global Circadian Rhythm Sleep Treatment Market Research Report 2025

Global Narcolepsy Treatment Market Research Report 2024

Bipolar Disorders and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insomnia Treatment Drugs Market Insights Forecast to 2030

Global Sleep Disorders Treatment Services Market Research Report 2025

Global Mouth Devices for Sleep Apnea Market Insights Forecast to 2030

Global Sleep Apnea Therapies Market Insights Forecast to 2030

Sleep Health Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insomnia Monitoring Equipment Market Insights Forecast to 2030

Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025

Ovulation Disorder Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Thyroid Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insomnia Therapy Market Research Report 2025

Global Bipolar Disorder Therapeutics Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Mental Disorders Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12T6869

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Haloperidol Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15F3292

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Serotonin Suppliments Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26K6727

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Major Tranquilizers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33X6826

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions